ddhCTP

1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

ddhCTP is an endogenously produced pyrimidine base analog with a Kd of 17.0 nM for LLDH and an IC50 of 55.8 μM for GAPDH. By inhibiting key metabolic enzymes such as GAPDH, ddhCTP reduces glycolytic flux and shifts metabolic flow toward the pentose phosphate pathway, thereby regulating the redox balance of cells. As a competitive CTP analog, ddhCTP terminates RNA synthesis by flavivirus RdRps and SARS-CoV-2 RdRp, and inhibits Zika virus replication in vivo. ddhCTP can be used in studies related to viral infections, COVID-19 and Zika virus infections.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • No. CAS: 2279171-34-3
  • Fòrmula: C9H14N3O13P3
  • Peso molecular:465.14
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) ddhCTP

More

Ver todos los productos específicos de isoformas DNA/RNA Synthesis

More

Ver todos los productos específicos de isoformas Endogenous Metabolite

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00